SBF's Lawyers Say He Needs ADHD, Anti-Depressant Medications in Jail - The Messenger
It's time to break the news.The Messenger's slogan

SBF’s Lawyers Say He Needs ADHD, Anti-Depressant Medications in Jail

Bankman-Fried uses Adderall for ADHD and an Emsam patch to treat depression

Bankman-Fried is scheduled to go on trial on Oct. 3.Angela Weiss/Getty Images

The lawyers for FTX founder Sam Bankman-Fried said the former Crypto King needs his anti-depressants and ADHD medications in jail.

Bankman-Fried has been prescribed an Emsam patch for depression for five years and Adderall for ADHD for three years, according to a letter sent by his lawyers to a federal judge in New York, which was reviewed by The Messenger. Bankman-Fried previously said he was willing to pay $250,000 cash bail when he was first arrested last year in order to avoid jail due to his conditions.

A federal judge threw Bankman-Fried in a Brooklyn jail notorious for its horrible conditions on Friday while he waits for his upcoming trial on fraud charges. The judge found that Bankman-Fried’s decision to leak private letters from his former girlfriend, a star witness against him, amounted to witness intimidation and jury tampering.

“When Mr. Bankman-Fried was remanded to custody on August 11, 2023, he was only able to bring a small supply of the above-described medications that will last for a few days,” wrote his lawyer, Christian R. Everdell of Cohen and Gresser. 

Everdell asked the judge to submit an order directing the jail where Bankman-Fried is being held, Metropolitan Detention Center, to ensure he has “continuous access” to his medications.

Metropolitan Detention Center did not immediately respond to The Messenger's request for comment.

Businesswith Ben White
Sign up for The Messenger’s free, must-read business newsletter, with exclusive reporting and expert analysis from Chief Wall Street Correspondent Ben White.
 
By signing up, you agree to our privacy policy and terms of use.
Thanks for signing up!
You are now signed up for our Business newsletter.